Patents by Inventor Michael Lyne

Michael Lyne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070043111
    Abstract: Ifenprodil is useful for the treatment of pain.
    Type: Application
    Filed: October 21, 2004
    Publication date: February 22, 2007
    Inventors: John Brew, Robin Bannister, Andrew Baxter, Alan Rothaul, Michael Lyne
  • Publication number: 20070043112
    Abstract: A non-opioid analgesic is used for the treatment of intermittent or episodic pain experienced by a patient undergoing chronic pain treatment with an opioid analgesic.
    Type: Application
    Filed: October 21, 2004
    Publication date: February 22, 2007
    Inventors: John Brew, Robin Bannister, Andrew Baxter, Alan Rothaul, Michael Lyne
  • Publication number: 20060063753
    Abstract: The invention relates to the use of nefopam for the manufacture of a medicament for the treatment of nausea, dizziness, blurred vision and emesis.
    Type: Application
    Filed: June 17, 2003
    Publication date: March 23, 2006
    Inventors: Robin Bannister, Michael Lyne
  • Publication number: 20060040905
    Abstract: (+)-Nefopam is formulated for intranasal administration, for use in the treatment of pain.
    Type: Application
    Filed: June 17, 2003
    Publication date: February 23, 2006
    Inventor: Michael Lyne
  • Publication number: 20050222205
    Abstract: Ifenprodil is useful for the treatment of pain, e.g. on administration intranasally or by another route that avoids first-pass metabolism.
    Type: Application
    Filed: May 6, 2003
    Publication date: October 6, 2005
    Inventors: John Brew, Robin Bannister, Andrew Douglas Baxter, Alan Rothaul, Michael Lyne
  • Publication number: 20040086905
    Abstract: The invention provides human lipid-associated molecules (LIPAM) and polynucleotides which identify and encode LIPAM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LIPAM.
    Type: Application
    Filed: August 6, 2003
    Publication date: May 6, 2004
    Inventors: Debopriya Das, Monique G Yao, Chandra S Arvizu, Mariah R Baughn, Yan Lu, April J A Hafalia, Narinder K Chawla, Jennifer A Griffin, Dyung Aina M Lu, Henry Yue, Li Ding, Vicki S Elliott, Ian J Forsythe, Jayalaxmi Ramkumar, Ameena R Gandhi, Craig H Ison, Y Tom Tang, Brooke M Emerling, Cynthia D Honchell, Bridget A Warren, Michael Lyne, Ines Barroso